SURFACE ONCOLOGY, INC.: revenue
| Value | {"amount": 0, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | SURFACE ONCOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/15e3ea19-1f77-4766-9bb0-3315e8a7df20
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001718108-21-000013Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001718108/revenue/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/15e3ea19-1f77-4766-9bb0-3315e8a7df20
History
- supersedes {"amount": 15360000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001564590-20-009521)